NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 01:54PM ET
10.99
Dollar change
-0.07
Percentage change
-0.63
%
IndexRUT P/E- EPS (ttm)- Insider Own20.36% Shs Outstand43.35M Perf Week-1.35%
Market Cap476.42M Forward P/E- EPS next Y-1.96 Insider Trans13.26% Shs Float34.52M Perf Month-16.43%
Income- PEG- EPS next Q-0.48 Inst Own38.15% Short Float9.09% Perf Quarter-
Sales- P/S- EPS this Y78.64% Inst Trans9.22% Short Ratio5.26 Perf Half Y-
Book/sh-5.66 P/B- EPS next Y-6.45% ROA- Short Interest3.14M Perf Year-
Cash/sh2.39 P/C4.60 EPS next 5Y38.22% ROE- 52W Range8.89 - 24.50 Perf YTD-53.49%
Dividend Est.- P/FCF- EPS past 5Y- ROI- 52W High-55.14% Beta-
Dividend TTM- Quick Ratio5.66 Sales past 5Y3522.02% Gross Margin- 52W Low23.62% ATR (14)1.17
Dividend Ex-Date- Current Ratio6.29 EPS Y/Y TTM- Oper. Margin- RSI (14)42.24 Volatility8.38% 12.43%
Employees291 Debt/Eq0.10 Sales Y/Y TTM- Profit Margin- Recom1.29 Target Price25.71
Option/ShortNo / Yes LT Debt/Eq0.08 EPS Q/Q- Payout- Rel Volume0.35 Prev Close11.06
Sales Surprise1.22% EPS Surprise-202.22% Sales Q/Q- EarningsMay 06 AMC Avg Volume596.10K Price10.99
SMA201.08% SMA50-26.39% SMA200-32.48% Trades Volume146,473 Change-0.63%
Date Action Analyst Rating Change Price Target Change
Feb-24-25Initiated Stifel Buy $25
Feb-24-25Initiated Piper Sandler Overweight $26
Feb-24-25Initiated Leerink Partners Outperform $28
Feb-24-25Initiated Lake Street Buy $30
Feb-24-25Initiated BofA Securities Buy
Feb-20-25Initiated Robert W. Baird Neutral $20
Feb-20-25Initiated Ladenburg Thalmann Neutral $20
Apr-24-25 11:44AM
Apr-19-25 05:30AM
Apr-16-25 04:05PM
Apr-09-25 07:30AM
Mar-28-25 06:00AM
04:45PM Loading…
Mar-27-25 04:45PM
Mar-25-25 04:02PM
Mar-03-25 12:59PM
Feb-27-25 07:00AM
Feb-21-25 09:35AM
Jan-31-25 05:56PM
06:34AM
Jan-30-25 12:55PM
Jan-29-25 10:34PM
Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mensinger MikeChief Product OfficerJan 31 '25Buy17.0033,350566,95059,019Feb 03 08:30 PM
Mensinger MikeChief Product OfficerJan 31 '25Sale17.001322125,669Feb 03 08:30 PM
Wellington Hadley Harbor Aggre10% OwnerJan 31 '25Buy17.001,000,00017,000,0003,901,599Feb 03 04:49 PM